Abvc Biopharma, Inc.
ABVCNasdaqCIK 1173313HealthcareFiscal year ends Dec 31
Reports and events: 428 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2912:22 ET | DEF 14A | Proxy statementPeriod 2026-10-28 | 0001213900-26-104509 |
| 2026-08-2708:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-094152 |
| 2026-08-1216:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-088348 |
| 2026-08-1211:50 ET | 8-K/A | 8.01 Other events | 0001213900-26-088165 |
| 2026-08-0421:12 ET | 8-K | 8.01 Other events | 0001213900-26-084846 |
| 2026-07-0216:01 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-074949 |
| 2026-05-1807:22 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-058104 |
| 2026-03-2716:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-035499 |
| 2026-03-0516:29 ET | DEF 14A | Proxy statementPeriod 2026-03-26 | 0001213900-26-024122 |
| 2026-03-0316:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-023063 |
| 2026-03-0316:19 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-09-30 | 0001213900-26-023062 |
| 2026-03-0316:14 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001213900-26-023054 |
| 2026-01-1616:30 ET | 8-K/A | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-005165 |
| 2025-11-0307:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-104900 |
| 2025-11-0319:39 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-104811 |
| 2025-10-3008:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-103799 |
| 2025-09-1219:16 ET | 8-K/A | 4.01 Change of auditor | 0001213900-25-086952 |
| 2025-08-1407:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-076018 |
| 2025-08-1316:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-075644 |
| 2025-07-1817:04 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-065728 |
| 2025-07-1516:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-064283 |
| 2025-06-0416:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-051144 |
| 2025-06-0316:01 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-25-050762 |
| 2025-05-3016:30 ET | 8-K/A | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-049491 |
| 2025-05-1616:30 ET | DEF 14A | Proxy statementPeriod 2025-06-03 | 0001213900-25-044910 |
| 2025-05-1416:30 ET | 8-K/A | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-043354 |
| 2025-05-1408:30 ET | 8-K/A | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042982 |
| 2025-05-0616:30 ET | 8-K/A | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001213900-25-040194 |
| 2025-05-0216:30 ET | 8-K/A | 4.02 Non-reliance on financial statements | 0001213900-25-039184 |
| 2025-05-0108:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-038060 |
| 2025-04-3016:41 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-037676 |
| 2025-04-3016:30 ET | 8-K | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-037654 |
| 2025-04-1613:42 ET | 8-K/A | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-032468 |
| 2025-04-1516:30 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-032135 |
| 2025-04-1516:23 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-032118 |
| 2025-03-0716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-25-021713 |
| 2025-01-1318:56 ET | 8-K/A | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-002769 |
| 2025-01-0617:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-001211 |
| 2024-11-1409:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-097894 |
| 2024-11-1408:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001213900-24-097840 |
| 2024-11-0417:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-24-094178 |
| 2024-10-1817:23 ET | 8-K | 4.01 Change of auditor | 0001213900-24-089013 |
| 2024-09-1016:01 ET | 8-K | 8.01 Other events | 0001213900-24-077361 |
| 2024-08-2016:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-071145 |
| 2024-08-1507:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-069338 |
| 2024-08-1415:18 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068907 |
| 2024-07-2317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001213900-24-063627 |
| 2024-07-1216:05 ET | 8-K | 3.01 Delisting notice | 0001213900-24-061028 |
| 2024-06-2517:15 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-055809 |
| 2024-06-2417:15 ET | 8-K/A | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-055288 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.